| ▲ | FDA clears blood test to aid evaluation for Alzheimer's disease(medicine.washu.edu) | |
| 25 points by dabinat 2 hours ago | 2 comments | ||
| ▲ | ggm 6 minutes ago | parent | next [-] | |
Do we yet have any good avoidance or mitigation regimes, be they drug or otherwise for people who show positive on a test like this? The alternative is that it lets you put things in place for when you lose agency. Good as in scientifically proven. Not speculative fantasy. | ||
| ▲ | brandonb 39 minutes ago | parent | prev [-] | |
This Alzheimer's blood test, PrecivityAD2, is based on the p-tau217 biomarker. In one recent study, people very high p-tau217 had a 38% chance of progressing to cognitive impairment within 5 years vs 12% for those with low levels. The current tests cost about $200-300, so they're not unreasonable as a screening test. | ||